Conference
OA03.01 First-Line Nivolumab Monotherapy and Nivolumab plus Ipilimumab in Patients with Advanced NSCLC: Long-Term Outcomes from CheckMate 012
Authors
Gettinger S; Rizvi N; Chow L; Borghaei H; Brahmer J; Shepherd F; Ready N; Gerber D; Antonia S; Goldman JW
Volume
12
Pagination
pp. s250-s251
Publisher
Elsevier
Publication Date
January 2017
DOI
10.1016/j.jtho.2016.11.238
Conference proceedings
Journal of Thoracic Oncology
Issue
1
ISSN
1556-0864